Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Medicare Aduhelm Coverage Policy Overrules FDA: Can Two Wrongs Make A Right?
Jan 13 2022
•
By
Michael McCaughan
The draft NCD from CMS had a very different reading of the data than FDA. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Medicare
More from Government Payers